“Onset of Clinical Response with Deucravacitinib in Patients with Moderate to Severe Scalp Psoriasis: A Post Hoc Analysis of the Phase 3b/4 PSORIATYK SCALP Trial”, J of Skin, vol. 9, no. 2, p. s539, Mar. 2025, doi: 10.25251/skin.10.supp.539.